Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
Saved in:
| Title: | Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial. |
|---|---|
| Authors: | Qiao YL; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China., Wu T; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China., Li RC; Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China., Hu YM; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China., Wei LH; Peking University People's Hospital, Beijing, China., Li CG; National Institute for Food and Drug Control, Beijing, China., Chen W; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China., Huang SJ; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China., Zhao FH; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China., Li MQ; Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi, China., Pan QJ; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China., Zhang X; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.; Xinmi Maternal and Child Health Hospital, Xinmi, Henan, China., Li Q; Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China., Hong Y; The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China., Zhao C; Peking University People's Hospital, Beijing, China., Zhang WH; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China., Li YP; Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China., Chu K; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China., Li M; The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China., Jiang YF; The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China., Li J; National Institute for Food and Drug Control, Beijing, China., Zhao H; National Institute for Food and Drug Control, Beijing, China., Lin ZJ; Xiamen Innovax Biotech Company, Xiamen, Fujian, China., Cui XL; Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi, China., Liu WY; Funing Center for Disease Control and Prevention, Funing, Jiangsu, China., Li CH; Xinmi Maternal and Child Health Hospital, Xinmi, Henan, China., Guo DP; Yangcheng Maternal and Child Health Hospital, Yangcheng, Shanxi, China., Ke LD; Fengning Hospital of Traditional Chinese Medicine, Fengning, Hebei, China., Wu X; Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi, China., Tang J; Funing Center for Disease Control and Prevention, Funing, Jiangsu, China., Gao GQ; Xinmi Maternal and Child Health Hospital, Xinmi, Henan, China., Li BY; Yangcheng Maternal and Child Health Hospital, Yangcheng, Shanxi, China., Zhao B; Fengning Hospital of Traditional Chinese Medicine, Fengning, Hebei, China., Zheng FX; Xinmi Maternal and Child Health Hospital, Xinmi, Henan, China., Dai CH; Fengning Hospital of Traditional Chinese Medicine, Fengning, Hebei, China., Guo M; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China., Zhao J; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China., Su YY; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China., Wang JZ; National Institute for Food and Drug Control, Beijing, China., Zhu FC; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China., Li SW; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China., Pan HR; Xiamen Innovax Biotech Company, Xiamen, Fujian, China., Li YM; Xiamen Innovax Biotech Company, Xiamen, Fujian, China., Zhang J; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China., Xia NS; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Feb 01; Vol. 112 (2), pp. 145-153. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2105 |
|---|---|
| DOI: | 10.1093/jnci/djz074 |
